Edwards Thomas A.

CIK 00016482831 companyMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001648283

Recent Transactions

36 trades

Disposition to Issuer
ChemoCentryx, Inc.
Restricted Stock Unit
2022-10-20−15,723→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Common Stock
2022-10-20−143,306→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−12,287→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−13,352→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−8,342→ 0 total
Disposition to Issuer
ChemoCentryx, Inc.
Stock Option
2022-10-20−4,504→ 0 total
Award
ChemoCentryx, Inc.
Common Stock
2022-05-26+15,723→ 143,306 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2022-05-26+8,342→ 8,342 total
Award
ChemoCentryx, Inc.
Common Stock
2021-05-20+7,726→ 127,583 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2021-05-20+4,504→ 4,504 total
Sale
ChemoCentryx, Inc.
Common Stock
2021-03-02$70.03/sh−500→ 120,457 total
Sale
ChemoCentryx, Inc.
Common Stock
2021-03-02$70.08/sh−600→ 119,857 total
Sale
ChemoCentryx, Inc.
Common Stock
2021-02-09$70.03/sh−400→ 120,957 total
Sale
ChemoCentryx, Inc.
Common Stock
2021-02-02$61.29/sh−7,983→ 121,357 total
Sale
ChemoCentryx, Inc.
Common Stock
2021-02-02$60.71/sh−12,017→ 129,340 total
Sale
ChemoCentryx, Inc.
Common Stock
2020-12-28$61.50/sh−10,782→ 141,357 total
Sale
ChemoCentryx, Inc.
Common Stock
2020-12-24$61.18/sh−14,218→ 152,139 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2020-05-21+2,888→ 2,888 total
Award
ChemoCentryx, Inc.
Common Stock
2020-05-21+4,660→ 166,357 total
Award
ChemoCentryx, Inc.
Common Stock
2019-05-23+7,724→ 161,697 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2019-05-23+12,287→ 12,287 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2018-07-28+6,767→ 153,973 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2018-07-28−6,767→ 0 total
Award
ChemoCentryx, Inc.
Common Stock
2018-05-21+8,421→ 147,206 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2018-05-21+13,352→ 13,352 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2017-07-28−6,767→ 6,767 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2017-07-28+6,767→ 138,785 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2017-05-26−20,362→ 0 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2017-05-26+20,362→ 132,018 total
Award
ChemoCentryx, Inc.
Common Stock
2017-05-25+12,912→ 111,656 total
Exercise/Conversion
ChemoCentryx, Inc.
Common Stock
2016-07-28+6,767→ 98,744 total
Exercise/Conversion
ChemoCentryx, Inc.
Restricted Stock Units
2016-07-28−6,767→ 13,534 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2016-05-26+20,362→ 20,362 total
Purchase
ChemoCentryx, Inc.
Common Stock
2016-05-17$4.05/sh+50,000→ 91,977 total
Purchase
ChemoCentryx, Inc.
Common Stock
2016-05-16$4.05/sh+25,000→ 41,977 total
Award
ChemoCentryx, Inc.
Restricted Stock Units
2015-07-28+20,301→ 20,301 total

Companies

ChemoCentryx, Inc.
Director

Recent Filings

Address

C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE

MOUNTAIN VIEW, CA, 94043

View on SEC.gov